Blog

Monoclonal antibody (mAb) drug development is rapidly evolving, driven by growing demand for precision therapies and a regulatory push toward non-animal testing methods. In this dynamic environment, Human Skin Equivalent (HSE) models are emerging as a powerful preclinical tool, especially for mAbs targeting dermatologic conditions or systemic diseases with skin involvement. As the FDA moves to phase out…

The human body has a highly coordinated capacity for tissue repair, driven by tightly regulated signaling networks involving cytokines and growth factors. These mediators orchestrate immune activation, tissue clearance, angiogenesis, and extracellular matrix remodeling across the full continuum of healing. For researchers and developers in regenerative medicine, a deeper understanding of the inflammatory phase of wound healing and its…

Hip replacements, knee prostheses, bone fixation devices, and other orthopedic implants are designed to restore function and alleviate the pain experienced by patients with musculoskeletal conditions. However, when it comes to the performance of these implants, surface texture plays a pivotal role in determining their success and longevity within the body. Enhancing Osseointegration One of…

iFyber is excited to announce its participation in the upcoming Kilmer Conference, taking place in Orlando, FL, from February 4-6, 2025.  The team will present cutting-edge research on the application of Supercritical Carbon Dioxide (scCO2) inactivating viruses in birth tissue. The session explores the ability of scCO2 sterilization technology effectively inactivate porcine parvovirus in amnionic…